deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT00678145

Mechanisms of Hypoglycemia Associated Autonomic Failure

Sponsor: Albert Einstein College of Medicine

Conditions Autonomic Failure Diabetes Mellitus Hypoglycemia
Interventions Epinephrine Morphine sulfate exercise fructose naloxone
Updated 13 times since 2017 Last updated: Jan 12, 2021 Started: Mar 31, 2008 Primary completion: Aug 31, 2022 Completion: Aug 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Autonomic Failure and Diabetes Mellitus, this trial is ongoing. The trial is conducted by Albert Einstein College of Medicine and has accumulated 13 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Dec 2019 · 10 months · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Feb 2023 · 24 months · monthly snapshot~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  4. Feb 2023 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

  5. Feb 2021 — Feb 2023 [monthly]

    Active Not Recruiting PHASE2

▶ Show 8 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE2

  2. Jan 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  3. Dec 2019 — Jan 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  4. Feb 2019 — Dec 2019 [monthly]

    Recruiting PHASE2

  5. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE2

  6. Feb 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Completed → Recruiting · Phase: NA → PHASE2

  7. Feb 2017 — Feb 2018 [monthly]

    Completed NA

  8. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Albert Einstein College of Medicine
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Institutes of Health (NIH)
Data source: Albert Einstein College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations